跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EPOSIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
EPOSIN
Authorized
STANDARD
EPOSIN
Pharmachemie B.V.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a91670a9183582c2
Company
Pharmachemie B.V.
Type
Standard
Approval Details
Approval Id
a91670a9183582c2
Drug Approval Canada Name
EPOSIN
Product Name
EPOSIN
Status
Cancelled Pre Market
Status Date
2017-08-01
Din
02237428
Drug Class
Human
Dosage Form
Liquid
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01CB01 ETOPOSIDE
Atc Name
l 01 cb 01
Aig Number
0114567002
Company Name
Pharmachemie B.V.
Company Address
Swensweg 5, Po Box# 552, Haarlem, North Holland, Netherlands, 2003 RN
Company Detail Path
/organization/pharmachemie-b-v
Company Information
Pharmaceutical Company Name
Pharmachemie B.V.
Country Name
Netherlands
Province Name
noord-holland,country_nl
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Active Ingredients
ETOPOSIDE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a91670a9183582c2
Type
Standard
Back to Health Canada Approvals